In conclusion, we have established that genetically matched hiPSC-CMs can capture electrophysiological differences related to the KCNH2 mutation, with these differences also reflected in the occurrence of drug-induced arrhythmias. The gene discussed is KCNH2; the disease is cardiac arrhythmia.